Previous Survey Results
What do you see as most likely to limit the rate at which our industry implements continuous bioprocessing?
Please comment on your reason(s). %

Participant Comment
“Once someone demonstrates it as a robust, cost effective alternative that is superior to batch processing, the rest of us will follow. The uptake will be limited by the current capital infrastructure.”